RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

Trade The Pool vs FXFair

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

TTPL

Trade The Pool

FXFR

FXFair

TRADE THE POOL

METRIC

FXFAIR

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

—

$200,000

MAX FUNDING

—

$97

MIN COST

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

TRADE THE POOL DETAILS

STEPS: -phase
MARKETS: Stocks

FXFAIR DETAILS

STEPS: -phase

Trade The Pool PROS

+Min challenge cost of $97 is well below the industry average of $186.7, reducing entry cost
+Single-step funding process matches the best performers, beating the 1.6-step industry average
+Max funding of $200,000 provides substantial capital access for stock traders
+Stock market access offers a distinct asset class not available at many CFD or futures firms

Trade The Pool CONS

−Max funding of $200,000 is significantly below the industry average of $839,272.7
−No profit split data is provided to compare against the industry average of 84.7%
−No payout timing data is available to compare against the industry average of 6.5 days

FXFair PROS

+Country of operation is listed as Indonesia, indicating a defined operational base.
+A registered tag suggests some formal industry presence.
+No confirmed below-average financial metrics are currently on record.
+Listing on a comparison platform indicates an intent toward transparency.

FXFair CONS

−No trading or financial metrics are available to evaluate this firm objectively.
−Without data on profit split, funding, or costs, no comparison to industry averages is possible.
−Traders cannot assess payout speed, drawdown rules, or profit targets from available data.

PROPDNA VERDICT